Literature DB >> 2849743

Molecular lesions involved in the progression of a human breast cancer.

E Liu1, C Dollbaum, G Scott, C Rochlitz, C Benz, H S Smith.   

Abstract

Specific genetic alterations are observed in human breast cancer, but little is known about when these occur in the evolution of the disease. Three breast cancer effusions that occurred sequentially in a single patient were examined. Common cytogenic abnormalities were found in all effusion samples suggesting a single progenitor metastatic cell. Only the last effusion, however, exhibited a mutation of the c-K-ras gene and a loss of heterozygosity at the c-H-ras locus. These specific genetic abnormalities detected in the last effusion was correlated with improved in vitro growth of the primary cells, and with the ability to establish breast cancer cell lines. Thus a mutant ras gene and the loss of heterozygosity at the c-H-ras locus were associated with a more aggressive tumor phenotype occurring late in the course of this patient's disease and not with the initiation of the primary breast cancer, or in the establishment of metastases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849743

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 2.  Prostate cancer--biology of metastasis and its clinical implications.

Authors:  J T Dong; C W Rinker-Schaeffer; T Ichikawa; J C Barrett; J T Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  Molecular and cellular lesions associated with breast cancer progression.

Authors:  H S Smith; L C Chen; J L Ngo; B M Ljung
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

5.  Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors:  C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Loss of heterozygosity of the oestrogen receptor gene in breast cancer.

Authors:  H Iwase; J M Greenman; D M Barnes; L Bobrow; S Hodgson; C G Mathew
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

Review 7.  RAS as Supporting Actor in Breast Cancer.

Authors:  Mirco Galiè
Journal:  Front Oncol       Date:  2019-11-12       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.